Pharmacokinetics and pharmacodynamics of intravenously and subcutaneously administered pantoprazole in sheep (Ovis aries)
- PMID: 38865425
- PMCID: PMC11168663
- DOI: 10.1371/journal.pone.0304533
Pharmacokinetics and pharmacodynamics of intravenously and subcutaneously administered pantoprazole in sheep (Ovis aries)
Abstract
Abomasal ulcers are recognized in sheep of all ages, but research regarding therapeutic interventions is limited. Proton Pump Inhibitors (PPIs) such as pantoprazole, are clinically used with a paucity of evidence regarding efficacy in mature sheep. Intravenous and subcutaneously administered pantoprazole dosed at 1.0 mg/kg in adult sheep will increase the pH of abomasal fluid compared to pre-administration baseline. The objectives were to assess the effect of pantoprazole, after single and multiple administration, on abomasal fluid pH in adult sheep. A third objective was to describe the pharmacokinetic parameters of IV and SC pantoprazole. Four clinically healthy adult Southdown ewes previously fitted with a gastrostomy tube in the abomasum were utilized in this randomized, 2-way cross-over trial. Ewes received pantoprazole (1.0 mg/kg) as a single and 3-dose regimen (every 24 hours). After a 10 day washout period the reverse treatment was applied. Blood for analysis of pantoprazole concentration was collected intermittently for 24 hours, and abomasal fluid pH was measured at intervals for a 96-hour period. The pH of the abomasal fluid was higher in pantoprazole treatments for up to 24 hours after dosing. Following intravenous administration of pantoprazole to study ewes, elimination half-life, volume of distribution, and clearance of pantoprazole was estimated as 3.29 hours, 0.35 L/kg, and 65.26 mL/hr/kg respectively. After subcutaneous dosing, maximum concentration, time to maximum concentration, half-life of elimination, and volume of distribution, were estimated as 2604 ng/mL, 0.55 hours, 2.48 hours, and 0.37 L/kg. Additionally, the bioavailability was estimated as 83.33%. Pantoprazole administered IV or SC may be useful for treatment or prevention of abomasal ulcers in adult sheep.
Copyright: © 2024 Smith et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authorship has no competing interest with this work.
Figures



Similar articles
-
Comparative pharmacokinetics of intravenous and subcutaneous pantoprazole in sheep and goats.Vet J. 2024 Jun;305:106138. doi: 10.1016/j.tvjl.2024.106138. Epub 2024 May 16. Vet J. 2024. PMID: 38761957
-
Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves.Front Vet Sci. 2023 Jan 30;9:1101461. doi: 10.3389/fvets.2022.1101461. eCollection 2022. Front Vet Sci. 2023. PMID: 36794231 Free PMC article.
-
Pharmacokinetics and efficacy of intravenous famotidine in adult cattle.J Vet Intern Med. 2018 May;32(3):1283-1289. doi: 10.1111/jvim.15080. Epub 2018 Mar 23. J Vet Intern Med. 2018. PMID: 29572958 Free PMC article. Clinical Trial.
-
Pharmacokinetics of proton pump inhibitors in children.Clin Pharmacokinet. 2005;44(5):441-66. doi: 10.2165/00003088-200544050-00001. Clin Pharmacokinet. 2005. PMID: 15871633 Review.
-
Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.Aliment Pharmacol Ther. 1994;8 Suppl 1:39-46. doi: 10.1111/j.1365-2036.1994.tb00239.x. Aliment Pharmacol Ther. 1994. PMID: 8180293 Review.
References
-
- Marks SL, Kook PH, Papich MG, Tolbert MK, Willard MD. ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats. J Vet Intern Med. 2018;32(6):1823–40. Epub 2018/11/01. doi: 10.1111/jvim.15337 ; PubMed Central PMCID: PMC6271318. - DOI - PMC - PubMed
-
- Smith BP, editor. Large Animal Internal Medicine. 4th ed: Mosby Elsevier St Louis, Missouri; 2014.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources